104 related articles for article (PubMed ID: 15766466)
1. [Veracity of smokers' reports of abstinence at smoking cessation clinics].
Barrueco M; Jiménez Ruiz C; Palomo L; Torrecilla M; Romero P; Riesco JA
Arch Bronconeumol; 2005 Mar; 41(3):135-40. PubMed ID: 15766466
[TBL] [Abstract][Full Text] [Related]
2. [Weight gain and anxiety levels in recent ex-smokers].
Nerín I; Beamonte A; Gargallo P; Jiménez-Muro A; Marqueta A
Arch Bronconeumol; 2007 Jan; 43(1):9-15. PubMed ID: 17257558
[TBL] [Abstract][Full Text] [Related]
3. Utilizing exhaled carbon monoxide measurement with self-declared smoking cessation: enhancing abstinence effectiveness in Taiwanese outpatients.
Chen CC; Chang CH; Tsai YC; Tseng CW; Tu ML; Wang CC; Lin MC; Liu SF
Clin Respir J; 2015 Jan; 9(1):7-13. PubMed ID: 24345098
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
5. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
[TBL] [Abstract][Full Text] [Related]
6. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
Sigmon SC; Miller ME; Meyer AC; Saulsgiver K; Badger GJ; Heil SH; Higgins ST
Addiction; 2016 May; 111(5):903-12. PubMed ID: 26638126
[TBL] [Abstract][Full Text] [Related]
7. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation treatment in a real-life setting: the Greek experience.
Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
[TBL] [Abstract][Full Text] [Related]
9. Extended cognitive behavior therapy for cigarette smoking cessation.
Killen JD; Fortmann SP; Schatzberg AF; Arredondo C; Murphy G; Hayward C; Celio M; Cromp D; Fong D; Pandurangi M
Addiction; 2008 Aug; 103(8):1381-90. PubMed ID: 18855829
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
[TBL] [Abstract][Full Text] [Related]
12. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
Rose JE; Behm FM; Westman EC; Levin ED; Stein RM; Ripka GV
Clin Pharmacol Ther; 1994 Jul; 56(1):86-99. PubMed ID: 8033499
[TBL] [Abstract][Full Text] [Related]
13. Predictors of 10-year smoking abstinence in smokers abstinent for 1 year after treatment.
Álvarez Gutiérrez FJ; Ferrer Galván M; Ruiz Bernal A; Medina Gallardo JF; Romero Romero B; Sáez Díaz A; Romero Falcón A
Addiction; 2016 Mar; 111(3):545-51. PubMed ID: 26498919
[TBL] [Abstract][Full Text] [Related]
14. Should the threshold for expired-air carbon monoxide concentration as a means of verifying self-reported smoking abstinence be reduced in clinical treatment programmes? Evidence from a Malaysian smokers' clinic.
Wee LH; West R; Mariapun J; Chan CM; Bulgiba A; Peramalah D; Jit S
Addict Behav; 2015 Aug; 47():74-9. PubMed ID: 25889913
[TBL] [Abstract][Full Text] [Related]
15. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.
Jatlow P; Toll BA; Leary V; Krishnan-Sarin S; O'Malley SS
Drug Alcohol Depend; 2008 Dec; 98(3):203-9. PubMed ID: 18650033
[TBL] [Abstract][Full Text] [Related]
16. Predictors of initial abstinence in smokers enrolled in a smoking cessation program.
Amodei N; Lamb RJ
Subst Use Misuse; 2005; 40(2):141-9. PubMed ID: 15770881
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release buproprion, or both.
Swanson NA; Burroughs CC; Long MA; Lee RW
Mil Med; 2003 Oct; 168(10):830-4. PubMed ID: 14620649
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Croghan IT; Hurt RD; Dakhil SR; Croghan GA; Sloan JA; Novotny PJ; Rowland KM; Bernath A; Loots ML; Le-Lindqwister NA; Tschetter LK; Garneau SC; Flynn KA; Ebbert LP; Wender DB; Loprinzi CL
Mayo Clin Proc; 2007 Feb; 82(2):186-95. PubMed ID: 17290726
[TBL] [Abstract][Full Text] [Related]
19. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
[TBL] [Abstract][Full Text] [Related]
20. If at first you don't succeed: characterization of smokers with late smoking abstinence onset.
Leyro TM; Hendricks PS; Hall SM
Addict Behav; 2015 Jun; 45():34-8. PubMed ID: 25637886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
